VRDN

30.3403.50%
TW

Thomas W. Beetham

Chief Operating Officer

Mr. Thomas W. Beetham J.D., M.B.A., also known as Tom, serves as Chief Operating Officer at Viridian Therapeutics, Inc. since October 30, 2023. He served as Chief Legal Officer at Dianthus Therapeutics Inc. until September 11, 2023. He joined Viridian Therapeutics, Inc. on October 30, 2023. He served as Chief Legal Officer at Magenta Therapeutics, Inc. since June 14, 2021 until September 2023 and was its Secretary June 2021 until September 2023. He served as Executive Vice President of Corporate Development & Operations and Secretary at Kiniksa Pharmaceuticals, Ltd. until 2021 and had been its Chief Legal Officer since July 2015 until 2021. He served as Chief Legal Officer, Senior Vice President and General Counsel of Synageva BioPharma Corp. since October 2013 until June 2015. Mr. Beetham served as Vice President of Corporate Development at Synageva BioPharma Corp. Prior to New England Biolabs, Mr. Beetham was with Genzyme Corporation for seven years where, as a Senior Corporate Attorney. He was responsible for supporting Genzyme’s Oncology and Multiple Sclerosis business units. Before Genzyme, Mr. Beetham was an Attorney at Palmer & Dodge LLP. Mr. Beetham focuses his practice on business and securities law. Mr. Beetham joined Synageva in October of 2013. Prior to joining Synageva, from 2011 to 2013, Mr. Beetham was the General Legal Counsel for New England Biolabs, Inc., or Biolabs. He served with New England Biolabs, Inc. for two years, where he was responsible for all legal matters. He works with clients in the biotech, medical-device and high-technology industries and has represented privately held and public companies in venture-capital financings, registered public offerings, mergers and acquisitions and licensing transactions. Mr. Beetham works with a number of emerging businesses advising such clients on structure, formation, founder arrangements, seed and early and later stage venture capital financing. In addition, Mr. Beetham has experience as investor counsel in private equity investments and assists public companies with compliance with federal securities law. At the University of Rochester, Mr. Beetham was elected to Phi Beta Kappa; at law school, he was executive editor of the Boston College Law Review and at Boston College Carroll Graduate School of Management, where he received his MBA, he was elected to Gamma Beta Sigma Honor Society. Before law school, Mr. Beetham was a member of the United States National Rowing Team, where he represented the U.S. in several international competitions, including the 1993 World Rowing Championships where he won the gold medal. Mr. Beetham holds a J.D. from Boston College Law School, an M.B.A. from Boston College’s Carroll School of Management and a BA from the University of Rochester.

Positions